Meeting Coverage
Psych Congress
Psychiatry & Behavioral Health Learning Network
First-year care trajectories looked different than those seeing psychiatrists
Latest Psych Congress Meeting Coverage
Nearly half of hesitant prescribers cited safety and tolerability as their top concern
Comorbidities may complicate treatment and diagnosis
Most patients on twice-a-year doses of paliperidone palmitate remained relapse-free over 3 years
Treatment should be prescribed with cardiovascular risks in mind, says researcher
Most adverse events dissipated after second or third treatment with intranasal esketamine
Symptoms had some PAs saying they intended to leave their clinical posts sooner rather than later
Youth on Jornay PM saw significantly higher weight trajectories
SHORELINE trial found reduced depression symptoms even in those exiting study early
Even mild cases tied to reduced quality of life and high medical costs, survey showed
Analysis shows that many patients are treated for symptoms of the disorder before diagnosis
Potential add-on therapy also improved most individual depressive symptoms on MADRS
Even at 10 mg, the sleep aid resulted in few abnormal dreams or nightmares
Not much data to support efficacy or safety "as a surrogate hypnotic medication," researcher says
But atypical antipsychotic disappoints in borderline personality disorder